In model 1, the risk of MS in these participants increased in the ALT level ranges of 15–30 and 30–40 U/L compared with that in ALT <15 U/L, respectively (aOR, 2.42 [95% CI, 2.18–2.69]; aOR, 5.31 [95% CI, 4.68–6.02]). Here, GPT is linked to myeloid sarcoma.